Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 968 | 2019 |
Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines V Paleri, TG Urbano, H Mehanna, C Repanos, J Lancaster, T Roques, ... The Journal of Laryngology & Otology 130 (S2), S161-S169, 2016 | 147 | 2016 |
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy DC Oksuz, RJ Prestwich, B Carey, S Wilson, MS Senocak, A Choudhury, ... Radiation oncology 6, 1-11, 2011 | 95 | 2011 |
Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules M Cengiz, E Özyar, M Esassolak, M Altun, M Akmansu, M Şen, Ö Uzel, ... International Journal of Radiation Oncology* Biology* Physics 63 (5), 1347-1353, 2005 | 89 | 2005 |
Prognostic factors in lung cancer with brain metastasis M Şen, AS Demiral, R Çetingöz, H Alanyali, F Akman, D Şentürk, M Kinay Radiotherapy and oncology 46 (1), 33-38, 1998 | 80 | 1998 |
Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy? GF Williams, MTW Teo, M Sen, KE Dyker, C Coyle, RJD Prestwich Oral oncology 48 (5), 434-440, 2012 | 72 | 2012 |
Prognostic significance of EGF receptor expression in early glottic cancer AN Demiral, S Sarıoglu, B Birlik, M Sen, M Kınay Auris Nasus Larynx 31 (4), 417-424, 2004 | 72 | 2004 |
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma D Bird, AF Scarsbrook, J Sykes, S Ramasamy, M Subesinghe, B Carey, ... BMC cancer 15, 1-10, 2015 | 71 | 2015 |
Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors C Conway, R Chalkley, A High, K Maclennan, S Berri, P Chengot, ... The Journal of Molecular Diagnostics 14 (2), 104-111, 2012 | 68 | 2012 |
Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation E Bayman, RJD Prestwich, R Speight, L Aspin, L Garratt, S Wilson, ... Clinical oncology 26 (10), 636-642, 2014 | 63 | 2014 |
Phase 2, open-label, 1: 1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent … A Ruzsa, M Sen, M Evans, LW Lee, K Hideghety, S Rottey, P Klimak, ... Investigational new drugs 32, 1278-1284, 2014 | 60 | 2014 |
Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions E Ermiş, M Teo, KE Dyker, C Fosker, M Sen, RJD Prestwich Radiation Oncology 10, 1-9, 2015 | 55 | 2015 |
The role of split-course hypofractionated palliative radiotherapy in head and neck cancer KN Kancherla, DC Oksuz, RJD Prestwich, C Fosker, KE Dyker, CC Coyle, ... Clinical Oncology 23 (2), 141-148, 2011 | 53 | 2011 |
Assessment of outcomes with delayed 18F-FDG PET-CT response assessment in head and neck squamous cell carcinoma F Slevin, M Subesinghe, S Ramasamy, M Sen, AF Scarsbrook, ... The British Journal of Radiology 88 (1052), 20140592, 2015 | 48 | 2015 |
The prognostic role of the neutrophil-to-lymphocyte ratio in oropharyngeal carcinoma treated with chemoradiotherapy CA Young, LJ Murray, E Karakaya, HH Thygesen, M Sen, RJD Prestwich Clinical Medicine Insights: Oncology 8, CMO. S15476, 2014 | 48 | 2014 |
Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma RJD Prestwich, M Subesinghe, A Gilbert, FU Chowdhury, M Şen, ... Clinical radiology 67 (10), 966-975, 2012 | 45 | 2012 |
Radiotherapy for head and neck cancer: evaluation of triggered adaptive replanning in routine practice M Figen, D Çolpan Öksüz, E Duman, R Prestwich, K Dyker, K Cardale, ... Frontiers in oncology 10, 579917, 2020 | 43 | 2020 |
Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography? RJD Prestwich, J Sykes, B Carey, M Sen, KE Dyker, AF Scarsbrook Clinical Oncology 24 (8), 577-589, 2012 | 42 | 2012 |
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy—Update of the EORTC QLQ‐H&N35, Phase I S Singer, JI Arraras, I Baumann, A Boehm, WC Chie, R Galalae, ... Head & neck 35 (9), 1331-1338, 2013 | 40 | 2013 |
Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan I Oztop, B Demirkan, A Yaren, O Tarhan, B Sengul, C Ulukus, D Akin, ... Tumori Journal 90 (5), 514-516, 2004 | 40 | 2004 |